Niagen Bioscience Inc (NASDAQ:NAGE) does about 848.11K shares in volume on a normal day but saw 1150085 shares change hands in the recent trading day. The company now has a market cap of 1.06B USD. Its current market price is $13.52, marking an increase of 0.67% compared to the previous close of $13.43. The 52 week high reached by this stock is $13.53 whilst the lowest price level in 52 weeks is $2.31.
The consensus objective for the share price is $14.90, suggesting that the stock has a potential upside of 9.26% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on May 27, 2025 when Canaccord Genuity initiated the stock to “Buy” and issued a price target of $13. B. Riley Securities downgraded its price target at $6-$2.40.
The current price level is 21.26%, 54.20%, and 115.77% away from its SMA20, SMA50, and SMA200 respectively, with the NAGE price moving below the 50-day SMA on current market day. Niagen Bioscience Inc (NAGE) stock is up 14.77% over the week and 51.06% over the past month. Its price is 154.85% year-to-date and 372.73% over the past year.
To reach the target analysts have set, the stock logically needs to grow 9.26 percent from here.
Outstanding shares total 78.43M with insiders holding 34.44% of the shares and institutional holders owning 32.93% of the company’s common stock. The company has a return on investment of 24.35% and return on equity of 33.47%. The price to earnings ratio (P/E ratio) amounts to 78.29 while the forward price to earnings ratio is 56.44. The beta has a value of 2.10. Price to book ratio is 19.16 and price to sales ratio is 9.87.
